New study debunks right-wing claims about trans kids in the US: ‘I hope our paper cools heads’

New research has shown that fewer than one in 1,000 US adolescents with commercial insurance receives gender-affirming medication, despite increasingly hysterical right wing claims to the contrary.

Published in Jama Pediatrics on Monday (6 January), the figures revealed just how few adolescents with commercial insurance received gender-affirming medication, including puberty blockers and hormones, during a five-year period. 

The researchers analysed an insurance claims database that covered more than five million patients aged eight to 17 across all 50 states. And they discovered that only 926 adolescents with a gender-related diagnosis received puberty blockers between 2018 and 2022. 

The figures didn’t include youngsters covered by Medicaid, the federal health insurance programme for people on low incomes. 

“We are not seeing inappropriate use of this sort of care” Donald Trump. (Getty)

During

READ MORE OF THIS POST AT Pink News